News: Inditherm target Latin American market
AIM-listed Rotherham company, Inditherm, is looking to expand into Latin America and recently attended a major trade fair with the aim of finding distributors for its innovative medical products.
Manvers-based Inditherm has developed products using low voltage carbon polymer technology to provide heat. Its systems are used for patients undergoing operations which carry risk of inadvertent hypothermia and in neonatal wards.
Company representatives recently attended FIME, the Florida International Medical Exposition, for the very first time. Attracting over 50,000 visitors, the trade fair enables medical equipment professionals to showcase a diverse range of capital equipment, accessories and services.
The move comes after growth in export orders for the medical business was not seen in 2013. Resources for export activities were increased during the year and Inditherm believe that this will allow them to increase focus in this area of the business and drive progress with overseas distribution channels. Action has been taken following some disappointing performances from some distributors and some encouraging signs were seen at the start of 2014.
Inditherm showcased its Alpha perioperative patient warming system that is used in operating theatres, intensive care units and during the pre-operative period. Well over 6,000,000 patients worldwide have now been warmed by the system.
In the UK, NICE, a world leader in setting standards for high quality healthcare, published guidance in 2011 advising that the Inditherm patient warming mattress should be considered for use in patients at risk of inadvertent hypothermia. The NHS in England alone could save over £15m per annum if forced air warming was replaced by Inditherm's mattress for eligible procedures in most of the 3,030 operating theatres.
Also on show in Miami was CosyTherm, which uses the low voltage carbon polymer technology to help prevent hypothermia in new born babies. The systems are already highly popular in the UK and used in almost half of all NHS neonatal units, with that number still growing. The product is also gaining increased international recognition, with users in over 30 countries world-wide.
LifeStart, a new system launched at the 2013 Arab Health exhibition was also featured by Inditherm. A world first, the system facilitates the delaying of the clamping and cutting of the umbilical cord following childbirth by providing resuscitation at a newborn baby's bedside.
Nick Bettles, CEO at Inditherm, said: "Our attendance at FIME 2014 underlines our commitment to develop our distributor network as we work to drive forward our export sales. We firmly believe that the Latin American markets have the capability to deliver real growth and progress for Inditherm.
"We made over 50 contacts at the show, including distributors covering more than 15 Latin American countries. A number of these are very promising potential partners and we will be pursuing those opportunities over the coming months."
For the 12 months ended December 31 2013, Inditherm reported that turnover increased by 23% to just over £2m compared to £1.6m in 2012 and gross profit rose to £1.1m, up by 21% on the £960k in 2012.
Inditherm website
Images: Inditherm
Manvers-based Inditherm has developed products using low voltage carbon polymer technology to provide heat. Its systems are used for patients undergoing operations which carry risk of inadvertent hypothermia and in neonatal wards.
Company representatives recently attended FIME, the Florida International Medical Exposition, for the very first time. Attracting over 50,000 visitors, the trade fair enables medical equipment professionals to showcase a diverse range of capital equipment, accessories and services.
The move comes after growth in export orders for the medical business was not seen in 2013. Resources for export activities were increased during the year and Inditherm believe that this will allow them to increase focus in this area of the business and drive progress with overseas distribution channels. Action has been taken following some disappointing performances from some distributors and some encouraging signs were seen at the start of 2014.
Inditherm showcased its Alpha perioperative patient warming system that is used in operating theatres, intensive care units and during the pre-operative period. Well over 6,000,000 patients worldwide have now been warmed by the system.
In the UK, NICE, a world leader in setting standards for high quality healthcare, published guidance in 2011 advising that the Inditherm patient warming mattress should be considered for use in patients at risk of inadvertent hypothermia. The NHS in England alone could save over £15m per annum if forced air warming was replaced by Inditherm's mattress for eligible procedures in most of the 3,030 operating theatres.
Also on show in Miami was CosyTherm, which uses the low voltage carbon polymer technology to help prevent hypothermia in new born babies. The systems are already highly popular in the UK and used in almost half of all NHS neonatal units, with that number still growing. The product is also gaining increased international recognition, with users in over 30 countries world-wide.
LifeStart, a new system launched at the 2013 Arab Health exhibition was also featured by Inditherm. A world first, the system facilitates the delaying of the clamping and cutting of the umbilical cord following childbirth by providing resuscitation at a newborn baby's bedside.
Nick Bettles, CEO at Inditherm, said: "Our attendance at FIME 2014 underlines our commitment to develop our distributor network as we work to drive forward our export sales. We firmly believe that the Latin American markets have the capability to deliver real growth and progress for Inditherm.
"We made over 50 contacts at the show, including distributors covering more than 15 Latin American countries. A number of these are very promising potential partners and we will be pursuing those opportunities over the coming months."
For the 12 months ended December 31 2013, Inditherm reported that turnover increased by 23% to just over £2m compared to £1.6m in 2012 and gross profit rose to £1.1m, up by 21% on the £960k in 2012.
Inditherm website
Images: Inditherm
0 comments:
Post a Comment